Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Surgical Apparatus

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1577507

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1577507

Heart Defect Closure Devices

PUBLISHED:
PAGES: 177 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Heart Defect Closure Devices Market to Reach US$6.6 Billion by 2030

The global market for Heart Defect Closure Devices estimated at US$2.7 Billion in the year 2023, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Left Atrial Appendage (LAA) Closure Device, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$3.5 Billion by the end of the analysis period. Growth in the Congenital Heart Defect (CHD) Closure Device segment is estimated at 12.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.7 Million While China is Forecast to Grow at 18.2% CAGR

The Heart Defect Closure Devices market in the U.S. is estimated at US$742.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 18.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Heart Defect Closure Devices Market - Key Trends and Drivers Summarized

Why Are Heart Defect Closure Devices Crucial in Cardiovascular Health Management?

Heart defect closure devices are critical tools in the treatment of structural heart anomalies, providing minimally invasive solutions that significantly reduce the risks associated with congenital and acquired heart defects. These devices are primarily used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and ventricular septal defects (VSD), all of which can impair normal cardiac function and lead to complications like stroke, heart failure, and arrhythmias if left untreated. Traditionally, such defects required open-heart surgery, which carries a high risk of complications and a prolonged recovery period. Heart defect closure devices, however, offer a less invasive alternative by allowing cardiologists to seal these defects using catheter-based procedures. This approach not only minimizes trauma but also enables faster recovery times, making it a preferred option for both pediatric and adult patients. The ability of these devices to deliver safe and effective outcomes has revolutionized the treatment landscape, reducing the need for complex surgical interventions and making heart defect management more accessible. As a result, these devices have become a cornerstone of modern cardiovascular care, with ongoing advancements aiming to expand their indications and improve procedural efficiency.

What Are the Key Trends and Technological Advancements Shaping the Heart Defect Closure Device Market?

The heart defect closure device market is witnessing rapid advancements, driven by a combination of evolving clinical needs, technological innovations, and increased focus on patient-centric care. One of the most prominent trends is the development of next-generation, bioresorbable devices that offer temporary support and gradually dissolve after the defect is closed, eliminating the need for permanent implants. These bioresorbable devices reduce long-term complications, such as device erosion and interference with future procedures, thereby enhancing patient safety and outcomes. Another significant trend is the miniaturization of devices, which is enabling the treatment of smaller defects and expanding their use in neonatal and pediatric patients. These smaller, more flexible devices are designed to navigate complex anatomies with greater ease, reducing procedural risks and improving the success rate of defect closure in younger populations. In addition, the integration of advanced imaging technologies, such as 3D echocardiography and real-time MRI, is enhancing procedural precision by providing detailed visualizations of the heart’s structure during device placement. This is particularly beneficial for complex cases where precise positioning is critical for optimal outcomes. Furthermore, there is a growing emphasis on hybrid procedures that combine catheter-based and surgical techniques to treat multi-faceted or high-risk defects. These hybrid approaches allow for tailored treatment strategies, offering new possibilities for patients who were previously considered inoperable. Collectively, these trends and innovations are not only expanding the capabilities of heart defect closure devices but are also reshaping the clinical approach to congenital and structural heart defect management.

How Are Technological Innovations Improving the Performance and Safety of Heart Defect Closure Devices?

Technological innovations are playing a pivotal role in enhancing the performance, safety, and versatility of heart defect closure devices, addressing some of the longstanding challenges associated with traditional approaches. One of the most significant advancements is the use of new materials, such as nitinol, which offer superior flexibility and shape memory, allowing devices to conform more effectively to the contours of the heart. Nitinol’s biocompatibility also minimizes the risk of adverse reactions and promotes better integration with the cardiac tissue. Additionally, bioresorbable polymers are being increasingly utilized to create devices that provide temporary scaffolding and then degrade harmlessly over time, reducing the risk of long-term complications and the need for secondary procedures. Another breakthrough is the incorporation of coating technologies that enhance the hemocompatibility of devices, reducing the risk of thrombus formation and the need for long-term anticoagulation therapy. Moreover, real-time imaging integration, such as the use of intravascular ultrasound (IVUS) and 3D mapping systems, is providing clinicians with unparalleled accuracy during device deployment, ensuring precise placement and minimizing procedural errors. The development of remote-controlled and robotic-assisted systems is further improving procedural safety by offering enhanced maneuverability and stability, especially in complex anatomical settings. These advancements are not only making heart defect closure devices safer and more effective but are also paving the way for broader adoption in challenging cases, thereby improving the overall treatment landscape for patients with congenital and structural heart defects.

What Is Driving the Growth of the Heart Defect Closure Device Market?

The growth in the heart defect closure device market is driven by several factors, primarily influenced by increasing prevalence of congenital heart defects, advancements in minimally invasive technologies, and growing awareness of early intervention options. One of the main growth drivers is the rising incidence of congenital heart anomalies globally, which is leading to greater demand for safe and effective treatment options. Advances in diagnostic techniques, such as the use of high-resolution imaging in prenatal care, are enabling earlier detection of heart defects, thereby increasing the number of patients eligible for closure procedures. Additionally, the ongoing shift towards minimally invasive cardiac interventions is significantly boosting market growth, as these procedures offer reduced recovery times, lower complication rates, and improved patient satisfaction compared to traditional open-heart surgeries. Another critical factor is the growing adoption of catheter-based techniques in pediatric populations, driven by the need for safe, effective, and less invasive solutions for younger patients. The increasing availability of specialized pediatric devices is opening up new treatment possibilities for neonatal and infant patients, who often present unique anatomical and clinical challenges. Furthermore, rising healthcare expenditure and the expansion of specialized cardiac care centers in emerging markets are creating new opportunities for the adoption of these advanced therapeutic devices. The continuous investment in research and development by key market players is also contributing to the growth, as new devices with enhanced safety features and broader indications enter the market. Favorable reimbursement policies and regulatory support in regions like North America and Europe are further driving adoption, making heart defect closure devices a rapidly expanding segment within the broader cardiovascular device industry. These factors, combined with the growing focus on patient-centric care and long-term outcomes, are propelling the market forward, ensuring that heart defect closure devices remain at the forefront of innovative cardiovascular health management.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Encore Medical
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Lifetech Scientific Corporation
  • Meril Life Sciences Pvt., Ltd.
  • MicroPort Scientific Corporation
  • Occlutech US LLC
  • Sahajanand Medical Technologies Pvt., Ltd.
Show more
Product Code: MCP24300

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Defect Closure Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Congenital Heart Defects Drives Demand for Heart Defect Closure Devices
    • Here's the Story: How Growing Adoption of Minimally Invasive Procedures Expands the Addressable Market for Non-Surgical Closure Devices
    • Increasing Focus on Pediatric Cardiac Care Propels Market Growth for Advanced Closure Solutions
    • Advancements in Device Design and Materials Strengthen the Business Case for Next-Generation Heart Defect Closure Devices
    • Here's How the Shift Towards Catheter-Based Interventions Generates Opportunities for Transcatheter Closure Devices
    • Expansion of Hybrid Cardiac Procedures Transforms Market Dynamics by Offering Combined Surgical and Transcatheter Solutions
    • Emphasis on Reducing Recovery Time and Post-Operative Complications Sustains Demand for Minimally Invasive Devices
    • Growing Use of Imaging Technologies Enhances Precision in Device Placement and Improves Surgical Outcomes
    • Here's How Rising Adoption of Wearable Health Monitors Spurs Growth in Demand for Early Intervention Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Defect Closure Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Defect Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Left Atrial Appendage (LAA) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Left Atrial Appendage (LAA) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Congenital Heart Defect (CHD) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Congenital Heart Defect (CHD) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Patent Foramen Ovale (PFO) Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Patent Foramen Ovale (PFO) Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Heart Defect Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Heart Defect Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Heart Defect Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Heart Defect Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Heart Defect Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Defect Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Heart Defect Closure Devices by Closure Type - Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Heart Defect Closure Devices by Closure Type - Percentage Breakdown of Value Sales for Left Atrial Appendage (LAA) Closure, Congenital Heart Defect (CHD) Closure and Patent Foramen Ovale (PFO) Closure for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!